North America Remote Cardiac Monitoring Market to Grow at a CAGR of 31.3% to reach US$ 7,738.62 million Million from 2021 to 2028

North America Remote Cardiac Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Devices, Software, and Services) and End User (Hospitals and Clinics, Emergency Settings, Homecare Settings, and Others)

  • Report Code : TIPRE00025822
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 149
Buy Now

The remote cardiac monitoring market in North America is expected to grow from US$ 1,153.06 million in 2021 to US$ 7,738.62 million by 2028; it is estimated to grow at a CAGR of 31.3% from 2021 to 2028.



The US, Canada, and Mexico are major economies in North America. Continuous developments in telemedicine approach is the major factor driving the growth of the North America remote cardiac monitoring market. More than 85 million Americans, ~26% of the US population, suffer from CVDs, and ~7 million, i.e., 2.2% of the population, survive stroke. CVDs and stroke cost the US healthcare system more than US$ 320 billion and US$ 33 billion, respectively, each year. By 2030, the annual costs of CVDs and stroke are projected to balloon to nearly US$ 1 trillion. Thus, there is an urge to design strategies to increase the value of health care by enhancing the quality of care and lowering costs; offering patients better access to care, via telehealth, can help address this need.  As defined by Office for the Advancement of Telehealth, telehealth comprises the use of telecommunications and information technologies to share information as well as to remotely provide clinical care, health education, public health, and administrative services. It has the potential to help transform healthcare systems, simultaneously reducing costs as well as boosting quality, patient-centeredness, and patient satisfaction. To successfully treat heart-related diseases, including CVDs, health professionals encourage patients to make lifestyle changes, continue a regular course of medication, and rigorously follow the follow-up schedule. However, despite the potential health benefits of regular doctor appointments and tests, clinic visits may act as an imposition on patients’ daily lives. As a result, disruptions in follow-up have become a common issue. Further, this situation has worsened with the pandemic. Clinic visits and elective procedures were suspended, and patients avoided visiting clinics due to the fear of SARS-CoV-2 infection. As per the American College of Cardiology, the pandemic has disrupted every aspect of cardiovascular care delivery, and the adverse effects on the same would be last long if health systems fail to adapt to the changes quickly and efficiently. Telehealth helps health systems in overcoming a few of the systemic barriers in monitoring heart diseases and CVDs. Technological solutions address the challenges posed by physical distance and facilitate personal interactions between doctors and patients. The doctors can remotely monitor conditions that contribute to heart attack and stroke, providing an opportunity to implement primary and secondary cardiovascular prevention without asking patients to visit the clinics. Patients can get any tests done before the appointment at a lab close to their home; they can also measure their blood pressure with an automatic blood pressure cuff at home, local pharmacies, or senior centers. Telehealth appointments are more convenient than in-person clinic visits for both doctors and patients. The introduction of remote monitoring of health data using wireless devices that measure weight, blood pressure, blood sugar, pulse, and heart rhythm could further advance telehealth services. Moreover, the telemedicine approach uses remote patient monitoring systems or devices to keep a check on the health status of patients. Along with cardiac monitors, companies are also working on developing monitoring devices for hematology, including blood glucose monitors, and for respiratory diseases, including sleep apnea and respiratory rate monitors, which is further anticipated to drive the Remote Cardiac Monitoring market in North America.

Since the COVID-19 pandemic, the US has suspended all the non-urgent scheduled visits and hospital stays. They have transitioned to virtual health platforms, using wearable sensors at unprecedented rates to reduce virus exposure and the use of limited stocks of personal protective equipment. The FDA has also issued emergency clearance for multiple RPM devices to enable further physiological data collection in this age of social distancing. The COVID-19 pandemic has ushered in a new era of heart management with remote cardiac monitoring. These remote cardiac device monitors changed the game's rules during the COVID-19 pandemic by redefining how patients use the devices to interact with their caregivers. By recording the device and physiological data timely and then sending that data securely over the internet to a patient's health team, countless patients have been able to leave the emergency room, avoid in-person clinic visits, and thus reduce exposure to the novel coronavirus. The ability to remotely monitor cardiac devices has given patients confidence in an already stressful time. It has helped nurses free up more hospital beds, at the same time reducing the need for expensive and sometimes scarce protective equipment.The response to COVID-19 across Canada has resulted in physical distancing protocols in hospitals, and equipment clinics have responded with increased remote monitoring. There is a need to assess how changes in the health landscape due to COVID-19 have affected cardiovascular implantable electronic device (CIED) follow-up care for patients and device clinics in Canada and investigate whether changes are temporary or permanent. The lack of a unified, process-specific, and guideline-based approach to post-implantation care of cardiovascular implantable electronic devices (CIEDs) and inconsistent funding guidelines in all jurisdictions for hospital and remote visits are significant obstacles to the use of remote patient management strategies in Canada.

 Remote Cardiac Monitoring market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

North America Remote Cardiac Monitoring Market Segmentation        

North America Remote Cardiac Monitoring Market – By Product Type

  • Devices
    • Vital Signs Monitors
    • Heart Rate Monitors
    • Blood Pressure Monitors
    • Breath Monitors
    • Holter Monitors
    • Others
  • Software
    • Cloud Based Software
    • On-Premise Software
  • Services

North America Remote Cardiac Monitoring Market – By End User

  • Hospitals and Clinics
  • Emergency Settings
  • Homecare Settings
  • Others

North America Remote Cardiac Monitoring Market– By Country

  • US
  • Canada
  • Mexico

North America Remote Cardiac Monitoring Market-Companies Mentioned

  • Abbott
  • AMC Health
  • Biotronik, Inc.
  • Boston Scientific Corporation
  • GE Healthcare
  • Honeywell International Inc.
  • Koninklijke Philips N.V.
  • Medtronic
  • Nihon Kohden Corporation
  • OSI Systems, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

  1. Abbott
  2. AMC Health
  3. Biotronik, Inc.
  4. Boston Scientific Corporation
  5. GE Healthcare
  6. Honeywell International Inc.
  7. Koninklijke Philips N.V.
  8. Medtronic
  9. Nihon Kohden Corporation
  10. OSI Systems, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to North America Remote Cardiac Monitoring Market